News & Updates

Patients with chronic obstructive pulmonary disease (COPD) and allied conditions are at heightened risk of stroke, but treatment with mucolytic agents and the combination of inhaled corticosteroids (ICS) plus long-acting β2-agonists (LABA) may protect against the risk, as shown in a study.

The BNT162b2 mRNA vaccine proves to be highly effective against COVID-19 hospitalization and critical illness in adolescents aged 12 to 18 years, including those with pre-existing comorbidities, according to real-world data from the Overcoming COVID-19 surveillance network sponsored by the US CDC.

Trastuzumab plus endocrine therapy is just as effective as the combination of trastuzumab plus chemotherapy in the first-line treatment of Chinese patients with metastatic breast cancer (MBC) harbouring hormone receptor (HR) or HER2 mutation, with the added advantage of better tolerability, according to the results of the phase III SYSUCC-002 trial.

Regular use of a dihydropyridine calcium channel blocker (CCB) results in a 2-mm Hg decrease in visit-to-visit blood pressure variability (vvBPV), according to the results of a post hoc analysis of the SPRINT trial.

Substituting a portion of existing diet with a specially-formulated snack twice daily for 4 weeks leads to significant reduction in LDL-cholesterol (LDL-C) levels compared with similar control foods matched for calorie in patients with elevated LDL-C who are unable or unwilling to take statins, according to a study.